I-023

Interference Mix 1 (For Qualitative Use Only)

100-1,000 μg/mL each component in methanol, analytical standard, Cerilliant^®

• Synonym(e): Qualitative Interference Mixture
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: analytical standard
• Qualitätsniveau: 100
• Form: liquid
• Zusammensetzung: Acetaminophen, 1,000 μg/mL ; Caffeine, 1,000 μg/mL ; (-)-Cotinine, 1,000 μg/mL ; Ibuprofen, 1,000 μg/mL ; Naproxen, 1,000 μg/mL ; (-)-Nicotine, 1,000 μg/mL ; Phentermine, 100 μg/mL ; R,R(-)-Pseudoephedrine, List I, 100 μg/mL
• Verpackung: ampule of 1 mL
• Hersteller/Markenname: Cerilliant^®
• drug control: psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)
• Konzentration: 100-1,000 μg/mL each component in methanol
• Methode(n): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Anwendung(en): forensics and toxicology
• Format: multi-component solution
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs: acetaminophen; (-)-cotinine; R,R-(-)-pseudoephedrine; phentermine; caffeine; naproxen; ibuprofen and (-)-nicotine. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

Rechtliche Hinweise

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Sicherheitshinweise

• Piktogramme: GHS02,GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H225,H301 + H311 + H331,H370
• P-Sätze: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• Gefahreneinstufungen: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Zielorgane: Eyes,Central nervous system
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 2
• Flammpunkt (°F): 49.5 °F - closed cup
• Flammpunkt (°C): 9.7 °C - closed cup